moxalactam has been researched along with Neutropenia in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drusano, GL; McNamee, W; Standiford, HC; Tatem, BA | 1 |
Bow, EJ; Chubb, H; Conly, JM; Louie, TJ; Ramotar, K | 1 |
Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
Boas, J; Bruun, BG; Dombernowsky, P; Frimodt-Møller, N; Hansen, HH; Hansen, OP; Holländer, NH; Oturai, PS | 1 |
Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M | 1 |
Boughton, BJ; Brown, RM; Harris, RI; Perry, DJ; Rhodes, EG; Welch, RS | 1 |
Elliott, CR; Pater, JL | 1 |
Bezwoda, WR; Cassel, R; Derman, DP; Perkins, S | 1 |
Belch, A; Bow, EJ; Chow, A; Feld, R; Louie, TJ; Mandell, L; Miedzinski, L; Pater, J; Rachlis, A; Robson, HG | 1 |
7 trial(s) available for moxalactam and Neutropenia
Article | Year |
---|---|
Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacteroides; Drug Therapy, Combination; Escherichia coli; Feces; Hemorrhagic Disorders; Humans; Hypoprothrombinemias; Intestines; Moxalactam; Neoplasms; Neutropenia; Prothrombin Time; Ticarcillin; Tobramycin | 1984 |
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumours.
Topics: Adult; Aged; Antineoplastic Agents; Bacteremia; Bacterial Infections; Ceftriaxone; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neutropenia; Prospective Studies; Respiratory Tract Infections; Urinary Tract Infections | 1993 |
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome | 1991 |
Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef.
Topics: Agranulocytosis; Bacterial Infections; Drug Therapy, Combination; Fever; Humans; Immune Tolerance; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Moxalactam; Neutropenia; Prothrombin Time; Random Allocation; Tobramycin | 1987 |
The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Clinical Trials as Topic; Cloxacillin; Drug Therapy, Combination; Fever; Humans; Infection Control; Leukemia; Lymphoma; Moxalactam; Multicenter Studies as Topic; Neoplasms; Neutropenia; Prognosis; Random Allocation; Tobramycin | 1988 |
Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Cephalosporins; Cephradine; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Random Allocation; Tobramycin | 1985 |
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Canada; Clinical Trials as Topic; Drug Therapy, Combination; Female; Granulocytes; Humans; Leukemia; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Penicillin Resistance; Prognosis; Random Allocation; Ticarcillin; Tobramycin | 1985 |
2 other study(ies) available for moxalactam and Neutropenia
Article | Year |
---|---|
The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
Topics: Adolescent; Adult; Bacteria; Cefoperazone; Cefotaxime; Humans; Male; Microbial Sensitivity Tests; Moxalactam; Neutropenia | 1984 |
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Escherichia coli Infections; Female; Fever; Humans; Klebsiella Infections; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Moxalactam; Neutropenia; Pseudomonas Infections; Sarcoma; Ticarcillin; Tobramycin | 1984 |